Alva Review-Courier -

By Linda A. Johnson
AP Medical Writer 

1st drug OK'd for movement disorder caused by certain meds

 

April 12, 2017



TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for treating a neurological syndrome that causes uncontrollable body movements that can also interfere with speech, swallowing and breathing.

The sometimes-disabling disorder, tardive dyskinesia, is caused by some widely used prescription medicines for psychiatric and gastrointestinal disorders. It can surface while patients are on those medicines or years after they stop. It affects about 500,000 U.S. patients.

The Food and Drug Administration on Tuesday approved Ingrezza, developed by Neurocrine Biosciences, for treating...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020